Research graph
References from Quo Vadis Aspirin In Primary Prevention?. Local targets link to admitted publications; unresolved targets remain external evidence.
2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines
2019 · External reference
The multifaceted clinical readouts of platelet inhibition by low-dose aspirin
10.1016/j.jacc.2015.05.012 · 2015 · External reference
Final report on the aspirin component of the ongoing physicians' health study
10.1056/nejm198907203210301 · 1989 · External reference
Aspirin for primary prevention of atherosclerotic cardiovascular disease: advances in diagnosis and treatment
10.1001/jamainternmed.2016.2648 · 2016 · External reference
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
10.1136/bmj.324.7329.71 · 2002 · External reference
Effects of aspirin for primary prevention in persons with diabetes mellitus
10.1056/nejmoa1804988 · 2018 · External reference
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial
10.1016/s0140-6736(18)31924-x · 2018 · External reference
Effect of aspirin on cardiovascular events and bleeding in the healthy elderly
10.1056/nejmoa1805819 · 2018 · External reference
Coronary artery calcium for personalized allocation of aspirin in primary prevention of cardiovascular disease in 2019: the MESA study (multi-ethnic study of atherosclerosis)
10.1161/circulationaha.119.045010 · 2020 · External reference
Carotid ultrasound-based plaque score for the allocation of aspirin for the primary prevention of cardiovascular disease events: the multi-ethnic study of atherosclerosis and the atherosclerosis risk in communities study
10.1161/jaha.123.034718 · 2024 · External reference
Aspirin and cardiovascular risk in individuals with elevated lipoprotein(a): the multi-ethnic study of atherosclerosis
10.1161/jaha.123.033562 · 2024 · External reference
Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials
10.1016/s0140-6736(23)00215-5 · 2023 · External reference
